Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
about
Pathogenesis of osteoporosis: concepts, conflicts, and prospectsThe endocrine role of estrogens on human male skeletonBones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral densityCYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men.The ESR1 (6q25) locus is associated with calcaneal ultrasound parameters and radial volumetric bone mineral density in European men.Higher estrogen levels during pregnancy in Andean than European residents of high altitude suggest differences in aromatase activitySex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density--the osteoporotic fractures in men study.Sex steroid actions in male boneBone turnover markers predict hip bone loss in elderly European men: results of the European Male Ageing Study (EMAS).Estrogens and Androgens in Skeletal Physiology and Pathophysiology.Bone turnover predicts change in volumetric bone density and bone geometry at the radius in menAromatase activity and bone loss in men.The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?Molecular genetic studies of gene identification for osteoporosis: a 2004 update.Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in menReview article: Osteoporosis and inflammatory bowel disease.Proximal hip geometry is linked to several chromosomal regions: genome-wide linkage results from the Framingham Osteoporosis StudyVariable phenotypes associated with aromatase (CYP19) insufficiency in humans.Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based AnalysisThe association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study.Towards a diagnostic and therapeutic consensus in male osteoporosisCorrelations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of menPolymorphisms in the CYP19 gene that influence bone mineral density.Association of estrogen and aromatase gene polymorphisms with systemic lupus erythematosus.Estrogen and bone: insights from estrogen-resistant, aromatase-deficient, and normal men.Sex steroids and bone health in men.An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese menComparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density.Sex hormones, their receptors and bone health.Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength.Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons.Influence of insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 on bone health: results from the European Male Ageing Study.Genetic influences in sport and physical performance.Reproductive Hormones and Longitudinal Change in Bone Mineral Density and Incident Fracture Risk in Older Men: The Concord Health and Aging in Men Project.Association of aromatase (TTTAn) repeat polymorphism length and the relationship between obesity and decreased sperm concentration.Assessment of the role of 17beta-oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study.Free testosterone levels and implications on clinical outcomes in elderly men.Influence of aromatase inhibition on the bone-protective effects of testosterone.Elderly men with a history of distal radius fracture have significantly lower calcaneal bone density and free androgen index than age-matched controls.
P2860
Q24536164-B4080F4C-D43F-409C-B9EB-0582D6A5C52EQ27026164-B58A1823-CF3E-4F72-B9A6-408009976708Q33378962-4D34CD1C-D5BB-44E2-ABFF-106E824905ACQ33616702-20FC4021-88CB-4F66-AEAE-83BFD83674D0Q33739241-D4ECB521-97B7-4555-8470-815868B8B96EQ33961723-12B7FF48-3122-4F8E-92E1-54BFFC6EA32AQ33999034-AF41F362-B1CB-4C9F-ACCA-8D94DDDB70AFQ34113083-9F2AAD7B-1C86-40D0-9B3A-20BA29145976Q34437537-B5E10EFB-9E06-404D-81B1-4311416DB327Q34438834-2E73CFE3-0943-48E3-A99A-37927608700EQ34543980-FF4B1E7B-6C3E-409A-8386-B66D97361F89Q34544147-1F83BC57-F21C-4353-9491-AF053D11D43BQ35101538-1561D140-3B03-44D4-86C0-FDC2F6A6715AQ35229894-1F9E1F18-0C0F-4EE7-BF99-7CE179FEDD03Q35691688-C47C16FD-1A34-4F44-A4A4-13AA6A4D97D1Q35738927-64899322-1DF2-43F3-8729-DEA9420CA836Q35758313-D06C7564-84DC-4991-B1E5-2D032BD204B6Q35950352-2446E09B-B866-4DEE-BB0F-A5246B49C865Q35956583-6B63D980-E23D-437F-990E-70ECDFAF361EQ36045845-8D00D512-3A90-4475-B826-503B575C4200Q36328511-C9821C2F-EA26-41D3-A646-3F1BC79B5C63Q36564415-CA404B2D-91EF-4FE5-A9E2-7292F0582F79Q36732699-41C61F1C-3145-44ED-818A-3F0A090127F2Q36772834-8EA5A1DF-F203-420F-9D62-DCDB13C815E1Q36843064-65FEE093-ABEE-496F-8F97-34A524748FF4Q36909998-3EBD8D04-6687-454F-8794-F47D7A5F1096Q36995890-553C9F30-2801-4334-91B2-F4B9522968DEQ37036843-5A36B977-FE15-4A05-85E9-E73328C862D0Q37085340-0872600D-B532-45C5-954D-F647821AF1A7Q37130045-F35D04FD-74F4-4417-8B6C-68542334C14FQ37189981-5419D154-0587-4B48-95CB-49352A3C1240Q37502104-3ABDB52E-94F5-4ED9-800D-7B38AC9D5F42Q37576379-8610A92F-F4CD-4EB5-AD47-E75270C1331AQ37933316-CF6D9A3D-5311-4F48-9117-4B63A984A87DQ41307145-8BA5653C-C251-48F8-B3DD-8FF2C42D1EACQ42873496-939C92DF-EFEB-4697-814A-2E7E4E8601C6Q45097773-42935731-FEB4-4D0F-92E2-F08146EBA5A7Q46507213-F8139F87-8C74-4223-AD79-410B8882868EQ48307037-93ADD00D-7BCB-492B-AFD6-9A053A130DA2Q53671084-04CB2303-4D3B-4B28-8FFA-68C13C208E3E
P2860
Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Bioavailable estradiol and an ...... s in men over 70 years of age.
@en
Bioavailable estradiol and an ...... s in men over 70 years of age.
@nl
type
label
Bioavailable estradiol and an ...... s in men over 70 years of age.
@en
Bioavailable estradiol and an ...... s in men over 70 years of age.
@nl
prefLabel
Bioavailable estradiol and an ...... s in men over 70 years of age.
@en
Bioavailable estradiol and an ...... s in men over 70 years of age.
@nl
P2093
P356
P1476
Bioavailable estradiol and an ...... s in men over 70 years of age.
@en
P2093
Goemaere S
Kaufman JM
Van Pottelbergh I
P304
P356
10.1210/JC.2002-021691
P407
P577
2003-07-01T00:00:00Z